In our patient cohort, we detected a MSH2 germline mutation in an IDH-wildtype glioblastoma patient (NCI0392), who was diagnosed with Lynch syndrome and had a de novo HMP brain tumor. This evidence concerns the gene IDH1 and brain neoplasm.